Mass spectrometry in diagnostic oncoproteomics. - Wikidata - thesis-toulmin - TriplyDB

Mass spectrometry in diagnostic oncoproteomics.

Mass spectrometry in diagnostic oncoproteomics.

http://www.wikidata.org/entity/Q33224210

about

Proteomics in clinical prostate research.Aptamer directly evolved from live cells recognizes membrane bound immunoglobin heavy mu chain in Burkitt's lymphoma cells.A comparative study on proteomics between LNCap and DU145 cells by quantitative detection and SELDI analysis.

P2860

Q37817140-AE07D659-B87D-481F-A652-B8B95289803E Q38298244-0D6673E8-E1B3-491B-8CF9-3842F5D62450 Q39982271-0BEF2FF0-2DE8-4DA7-B047-A24574671D50

P2860

Mass spectrometry in diagnostic oncoproteomics.

http://www.wikidata.org/entity/Q33224210

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

name

Mass spectrometry in diagnostic oncoproteomics.

@ast

Mass spectrometry in diagnostic oncoproteomics.

@en

type

label

Mass spectrometry in diagnostic oncoproteomics.

@ast

Mass spectrometry in diagnostic oncoproteomics.

@en

prefLabel

Mass spectrometry in diagnostic oncoproteomics.

@ast

Mass spectrometry in diagnostic oncoproteomics.

@en

P1433

Q33224210-EAD04E59-D1E1-4225-B510-CCDCC9B78FDD

P1476

Q33224210-FD0C46D1-F398-4872-BE2A-1C34A774DB4B

P2093

Q33224210-9B3BD87E-4632-4C3E-8307-4C1F7F53A491

P2860

Q33224210-01621EA5-F864-4DAC-AF26-FEAAEA00DE3E

Q33224210-040F1B2E-D991-45E9-8428-692A1EEA1ED9

Q33224210-07508913-7DA2-45AF-B9BE-00E9AE41CD75

Q33224210-0C831A89-C641-4571-843B-9D6720C8B5A6

Q33224210-0F791E91-9B6F-4FE0-A82E-235CBC26E2A3

Q33224210-1631C315-70BC-4036-AA3A-A338F319784D

Q33224210-19A8A62C-5CDB-4BAC-A691-71CA2A9E4340

Q33224210-19FE7625-B6F3-4715-A57D-D2CF5ED6C124

Q33224210-25C233CC-719B-4CB1-B7BC-37E64F2B5168

Q33224210-285945BB-BB48-4E7F-97BE-644FF2B15550

P304

Q33224210-52CF903B-3CF7-4425-930C-618BE66B50BC

P31

Q33224210-1541F5FF-46C1-4295-B157-0009E127A1A8

P356

Q33224210-AEDFA8E1-5D4E-4689-9172-D4E9AD00C483

P433

Q33224210-E87556C8-461F-4EDD-AF23-D7851BF25A06

P478

Q33224210-01EA2F20-EAF3-4EB0-BD84-C5BDA85D02B6

P577

Q33224210-46417908-4079-4C3D-B507-70B5336D4766

P698

Q33224210-A0BD0FEF-BEF9-46CC-B67C-BF40E90F20DB

P356

P1433

Cancer Investigation

P1476

Mass spectrometry in diagnostic oncoproteomics.

@en

P2093

John Roboz

http://www.w3.org/2001/XMLSchema#string

P2860

Sequence tag identification of intact proteins by matching tanden mass spectral data against sequence data bases

Accurate quantitation of protein expression and site-specific phosphorylation

Identification of proteins in laser-microdissected small cell numbers by SELDI-TOF and Tandem MS

Computational protein biomarker prediction: a case study for prostate cancer

A data review and re-assessment of ovarian cancer serum proteomic profiling

Using decision forest to classify prostate cancer samples on the basis of SELDI-TOF MS data: assessing chance correlation and prediction confidence.

Mass spectrometry-based proteomics

Current developments in SELDI affinity technology

Proteinchip(R) surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures

Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays.

P304

465-478

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1081/CNV-67182

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16193645

http://www.w3.org/2001/XMLSchema#string